Amyloid-β - A reflection of risk or a preclinical marker?

Clifford R. Jack; Prashanthi Vemuri

doi:10.1038/s41582-018-0008-9

Amyloid-β - A reflection of risk or a preclinical marker?

Clifford R. Jack, Prashanthi Vemuri

Radiology

Research output: Contribution to journal › Short survey › peer-review

7 Scopus citations

Original language	English (US)
Pages (from-to)	319-320
Number of pages	2
Journal	Nature Reviews Neurology
Volume	14
Issue number	6
DOIs	https://doi.org/10.1038/s41582-018-0008-9
State	Published - Jun 1 2018

ASJC Scopus subject areas

Clinical Neurology
Cellular and Molecular Neuroscience

Access to Document

10.1038/s41582-018-0008-9

Cite this

@article{b41cdee9640f457b8aa8ab9acb698365,

title = "Amyloid-β - A reflection of risk or a preclinical marker?",

author = "Jack, {Clifford R.} and Prashanthi Vemuri",

note = "Funding Information: The authors wish to acknowledge the following for funding support: National Institutes of Health (R01 AG011378, R01 AG041851, R01 NS097495, R01 AG056366) and the Alexander Family Alzheimer{\textquoteright}s Disease Research Professorship of the Mayo Clinic.",

year = "2018",

month = jun,

day = "1",

doi = "10.1038/s41582-018-0008-9",

language = "English (US)",

volume = "14",

pages = "319--320",

journal = "Nature Reviews Neurology",

issn = "1759-4758",